For CEOs in the pharmaceutical industry, expansion decisions today are no longer just about growth—they are about control, resilience, regulatory certainty, and long-term positioning. In that context, Puerto Rico has quietly become one of the most strategic expansion destinations for U.S.-based pharmaceutical companies. Not because it is new—but because it is proven, aligned with U.S….
Read More